-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QCBD5fTJTHsZ3IHGR/5GYpxD80ZMg4U9dvXAw53KOBW55/Y2tmegpNSGhSlsg24G aQtDH00jejVgQY8qq2k08Q== 0001164710-02-500108.txt : 20020930 0001164710-02-500108.hdr.sgml : 20020930 20020930171530 ACCESSION NUMBER: 0001164710-02-500108 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020930 ITEM INFORMATION: FILED AS OF DATE: 20020930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGEN INTERNATIONAL INC /DE CENTRAL INDEX KEY: 0000916304 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 942852543 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23252 FILM NUMBER: 02777168 BUSINESS ADDRESS: STREET 1: 16020 INDUSTRIAL DR CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 3019848000 MAIL ADDRESS: STREET 1: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: IGEN INC /CA/ DATE OF NAME CHANGE: 19931216 8-K 1 f8-k_09302002.txt - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 30, 2002 Commission File Number 0-23252 IGEN INTERNATIONAL, INC. (Exact name of registrant) Delaware 94-2852543 (State of organization) (I.R.S. Employer Identification No) 16020 Industrial Drive, Gaithersburg Maryland 20877 (Address of principal executive offices and zip code) (301) 869-9800 (Registrant's telephone Number) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Item 9. REGULATION FD DISCLOSURE On September 30, 2002, Richard J. Massey, Ph.D., President & Chief Operating Officer, filed a Form 4 with the U.S. Securities and Exchange Commission disclosing that he has sold 140,000 shares of common stock of the Company. The Form 4 also reported that Dr. Massey, following the sale of these shares, holds directly 875,716 shares of common stock in the Company. These sales were made on behalf of Dr. Massey pursuant to a plan adopted under Rule 10b5-1 on September 23, 2002 covering 319,800 shares at a limit price of not less than $30.00. Dr. Massey has advised the Company that he will be using a portion of the proceeds to be received from the sale of stock under the Rule 10b5-1 plan to pay state and federal taxes associated with prior exercises of stock options, to repay a loan in the principal amount of $1,649,000 previously extended to him by the Company and to pay for other financial obligations. Signatures Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IGEN International, Inc. By: /s/ George V. Migausky -------------------------- George V. Migausky Vice President Chief Financial Officer Dated: September 30, 2002 -----END PRIVACY-ENHANCED MESSAGE-----